In addition, Kuang et al. presented that the group of gut microbiota-modified bile acids, hyodeoxycholic acid (HDCA) species, had abilities to alleviate non-alcoholic fatty liver disease (NAFLD) through activating farnesoid X receptor (FXR) [20]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.